Immune activation in myasthenia gravis: Soluble interleukin-2 receptor, interferon-γ and tumor necrosis factor-α levels in patients' serum

Paolo Confalonieri, Carlo Antozzi, Ferdinando Cornelio, Ornella Simoncini, Renato Mantegazza

Research output: Contribution to journalArticle


Soluble interleukin-2 receptor (sIL-2R), interferon-γ (IFN-γ) and tumor necrosis factor-α (TNF-α) levels were evaluated in serum from patients affected by myasthenia gravis (MG). sIL-2R titers were significantly increased in generalized and bulbar MG patients while ocular cases were not different from controls. Patients showing a recent clinical worsening had significantly higher sIL-2R titers when compared to the whole MG population. sIL-2R levels did not correlate with the corresponding anti-acetylcholine receptor antibody titer (Anti-AChR Ab). IFN-γ was not detected in serum of both MG patients and healthy subjects while TNF-α levels were not statistically different from controls. The finding of increased sIL-2R levels supports the hypothesis of circulating activated autoreactive T cells in myasthenic patients.

Original languageEnglish
Pages (from-to)33-36
Number of pages4
JournalJournal of Neuroimmunology
Issue number1
Publication statusPublished - 1993



  • Autoimmunity
  • Interferon-γ
  • Myasthenia gravis
  • Soluble interleukin-2 receptor
  • Tumor necrosis factor-α

ASJC Scopus subject areas

  • Immunology
  • Immunology and Allergy
  • Clinical Neurology
  • Neurology

Cite this